Modelling the effects of PPARβδ of innate inflammatory responses in lung tissues

Keyphrases

• Lung Tissue 100%
• Peroxisome Proliferator-activated Receptor 100%
• Innate Inflammatory Response 100%
• Mode of Action 27%
• Inflammation 18%
• LPS-induced Inflammation 18%
• Transrepression 18%
• Pulmonary Artery 18%
• Bronchi 18%
• Polar Interactions 18%
• Lung Inflammation 9%
• Metabolism 9%
• Anti-inflammatory Effect 9%
• Nuclear Receptor 9%
• Co-incubation 9%
• Mechanism of Action 9%
• Molecular Mechanism 9%
• Chemistry Method 9%
• Ligand Binding 9%
• Functional Outcome 9%
• GW0742 9%
• Computational Chemistry 9%
• Binding Profile 9%
• Rat Lung 9%
• Novel Therapies 9%
• GSK3787 9%
• Binding Pocket 9%
• Signal Control 9%
• Binding Energy 9%
• GSK0660 9%
• Pulmonary Parenchyma 9%
• Delta Mechanism 9%
• Inflammatory-related Diseases 9%
• Inflammatory Lung Disease 9%
• Inflammation Model 9%
• Inflammation Inhibition 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Inflammation 100%
• Peroxisome Proliferator Activated Receptor 100%
• Peroxisome Proliferator Activated Receptor Delta 100%
• Mode of Action 27%
• Lipopolysaccharide-Induced Inflammation 18%
• Rat 18%
• Anti-Inflammatory Drug 9%
• Antiinflammatory Activity 9%
• Cell Nucleus Receptor 9%
• [4 [2 (3 Fluoro 4 Trifluoromethylphenyl) 4 Methyl 5 Thiazolylmethylthio] 2 Methylphenoxy]acetic Acid 9%
• Delta Opiate Receptor Agonist 9%
• Delta Opiate Receptor Antagonist 9%
• 3 [(4 Anilino 2 Methoxyphenyl)sulfamoyl] 2 Thenoic Acid Methyl Ester 9%
• Diseases 9%
• Pneumonia 9%